MaxCyte, Inc. Investment Income, Interest
MaxCyte, Inc. (MXCT) reported Investment Income, Interest of $1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- MaxCyte, Inc. investment income, interest for the quarter ending 2026-06-30 was $1.36M, a 27.38% decline year-over-year.
- MaxCyte, Inc. investment income, interest for the quarter ending 2026-03-31 was $1.44M, a 29.45% decline year-over-year.
- MaxCyte, Inc. investment income, interest for the quarter ending 2025-12-31 was $1.63M, a 29.25% decline year-over-year.
- MaxCyte, Inc. investment income, interest for the quarter ending 2025-09-30 was $1.73M, a 30.57% decline year-over-year.
- MaxCyte, Inc. investment income, interest for fiscal 2025 was $7.27M, a 28.35% decline from fiscal 2024.
- MaxCyte, Inc. investment income, interest for fiscal 2024 was $10.14M, a 2.26% decline from fiscal 2023.
- MaxCyte, Inc. investment income, interest for fiscal 2023 was $10.38M, a 164.90% increase from fiscal 2022.
- MaxCyte, Inc. investment income, interest for fiscal 2022 was $3.92M, a 2497.48% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.36M 10-Q · filed 2026-08-13 | $2.79M 10-Q · filed 2026-08-13 | $4.42M derived: sum of 3 quarters · filed 2026-08-13 | $6.16M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-13 | $3.06M derived: sum of 2 quarters · filed 2026-05-13 | $4.80M derived: sum of 3 quarters · filed 2026-05-13 | $6.67M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $3.36M derived: sum of 2 quarters · filed 2026-03-25 | $5.23M derived: sum of 3 quarters · filed 2026-08-13 | $7.27M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-13 | $3.60M derived: sum of 2 quarters · filed 2026-08-13 | $5.64M 10-Q · filed 2025-11-13 | $7.94M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.87M 10-Q · filed 2026-08-13 | $3.90M 10-Q · filed 2026-08-13 | $6.21M derived: sum of 3 quarters · filed 2026-08-13 | $8.70M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-13 | $4.34M derived: sum of 2 quarters · filed 2026-05-13 | $6.83M derived: sum of 3 quarters · filed 2026-05-13 | $9.43M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.80M derived: sum of 2 quarters · filed 2026-03-25 | $7.39M derived: sum of 3 quarters · filed 2026-03-25 | $10.14M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $2.50M 10-Q · filed 2025-11-13 | $5.09M derived: sum of 2 quarters · filed 2025-11-13 | $7.84M 10-Q · filed 2025-11-13 | $10.66M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.59M 10-Q · filed 2025-08-06 | $5.34M 10-Q · filed 2025-08-06 | $8.16M derived: sum of 3 quarters · filed 2025-08-06 | $10.86M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $2.75M 10-Q · filed 2025-05-08 | $5.57M derived: sum of 2 quarters · filed 2025-05-08 | $8.27M derived: sum of 3 quarters · filed 2025-05-08 | $10.83M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.52M derived: sum of 2 quarters · filed 2025-03-11 | $8.08M derived: sum of 3 quarters · filed 2025-03-11 | $10.38M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $2.70M 10-Q · filed 2024-11-06 | $2.70M 10-Q · filed 2023-11-08 | $5.26M derived: sum of 2 quarters · filed 2024-11-06 | $7.56M 10-Q · filed 2024-11-06 | $7.56M 10-Q · filed 2023-11-08 | $9.51M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $2.56M 10-Q · filed 2024-08-06 | $2.56M 10-Q · filed 2023-08-09 | $4.86M 10-Q · filed 2024-08-06 | $4.86M 10-Q · filed 2023-08-09 | $6.81M derived: sum of 3 quarters · filed 2024-08-06 | $8.20M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $2.30M 10-Q · filed 2024-05-07 | $2.30M 10-Q · filed 2023-05-10 | $4.25M derived: sum of 2 quarters · filed 2024-05-07 | $5.64M derived: sum of 3 quarters · filed 2024-05-07 | $6.12M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $3.35M derived: sum of 2 quarters · filed 2024-03-12 | $3.83M derived: sum of 3 quarters · filed 2024-03-12 | $3.92M 10-K · filed 2024-03-12 | $3.92M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $1.39M 10-Q · filed 2023-11-08 | $1.87M derived: sum of 2 quarters · filed 2023-11-08 | $1.96M 10-Q · filed 2023-11-08 | $2.05M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $478.70K 10-Q · filed 2023-08-09 | $570.50K 10-Q · filed 2023-08-09 | $651.30K derived: sum of 3 quarters · filed 2023-08-09 | $702.80K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $91.80K 10-Q · filed 2023-05-10 | $172.60K derived: sum of 2 quarters · filed 2023-05-10 | $224.10K derived: sum of 3 quarters · filed 2023-05-10 | $232.70K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $80.80K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $132.30K derived: sum of 2 quarters · filed 2023-03-15 | $140.90K derived: sum of 3 quarters · filed 2023-03-15 | $150.80K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $51.50K 10-Q · filed 2022-11-09 | $60.10K derived: sum of 2 quarters · filed 2022-11-09 | $70.00K 10-Q · filed 2022-11-09 | $80.30K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $8.60K 10-Q · filed 2022-08-10 | $18.40K 10-Q · filed 2022-08-10 | $28.80K derived: sum of 3 quarters · filed 2022-08-10 | $35.60K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $9.80K 10-Q · filed 2022-05-09 | $20.20K derived: sum of 2 quarters · filed 2022-05-09 | $27.00K derived: sum of 3 quarters · filed 2022-05-09 | $32.20K derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $10.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $17.20K derived: sum of 2 quarters · filed 2022-03-22 | $22.40K derived: sum of 3 quarters · filed 2022-03-22 | $65.90K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $6.80K 10-Q · filed 2021-11-10 | $12.00K derived: sum of 2 quarters · filed 2021-11-10 | $55.50K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $5.20K 10-Q · filed 2021-09-13 | $48.70K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $206.10K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |